View of aberrant FGFR dimer over-signaling.
Excerpt from a 3-minute MOA that examines the human fibroblast growth factor receptor family and an inhibitor of FGFR (1-4) currently being investigated for human cancers oncogenically driven by FGFR genomic aberrations.
<< Back
